journal of pharmaceutical research international

Journal of Pharmaceutical Research International

List of Reviewers 2013

List of Reviewers 2014

List of Reviewers 2015

List of Reviewers 2016

List of Reviewers 2017

List of Reviewers 2018

List of Reviewers 2019

List of Reviewers 2020

List of Reviewers 2021

List of Reviewers 2022

© Copyright 2010-Till Date, Journal of Pharmaceutical Research International. All rights reserved.

• Paper Archives
• Journal Indexing
• Research Conference
• Add Journal

Searching By

• Search More ...

Description

Last modified: 2019-08-31 17:56:29

• No Archives

Advertisement

Journal of International Pharmaceutical Research

Subject Area and Category

• Pharmaceutical Science

Editorial office of Journal of International Pharmaceutical Research

Publication type

2010-2011, 2013-2020

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents.

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years. Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

Leave a comment

Name * Required

Email (will not be published) * Required

* Required Cancel

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Follow us on @ScimagoJR Scimago Lab , Copyright 2007-2024. Data Source: Scopus®

Cookie settings

Cookie Policy

Legal Notice

Privacy Policy

Pharmaceutical Research

An Official Journal of the American Association of Pharmaceutical Scientists

• Publishes papers on small drug molecules, biotechnology products including genes, peptides, proteins, vaccines, and genetically engineered cells.
• Known for excellent author service with 97% of authors expressing interest to publish again.
• Publishes twelve issues a year.

Societies and partnerships

Latest issue

Volume 41, Issue 4

Latest articles

Nicotinamide mononucleotide and nicotinamide riboside reverse ovarian aging in rats via rebalancing mitochondrial fission and fusion mechanisms.

• Nazli Pinar Arslan
• Mesut Taskin
• Osman Nuri Keles

Evaluation of Various Approaches to Estimate Transplacental Clearance of Vancomycin for Predicting Fetal Concentrations using a Maternal–Fetal Physiologically Based Pharmacokinetic Model

• Qiushi Wang

Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer

• Nanami Okamoto
• Masaki Higashino
• Kiyohiko Sugano

Assessment of Tunable Resistive Pulse Sensing (TRPS) Technology for Particle Size Distribution in Vaccine Formulations – A Comparative Study with Dynamic Light Scattering

• Rahul Misra
• Marina Kirkitadze

Selective Delivery of Clindamycin Using a Combination of Bacterially Sensitive Microparticle and Separable Effervescent Microarray Patch on Bacteria Causing Diabetic Foot Infection

• Nurul Fauziah
• Nur Annisa Safirah
• Andi Dian Permana

Journal updates

The aaps journals make use of portable peer review.

If your manuscript has been declined, and you are planning to submit your article to another of the four AAPS journals ( AAPS Open, The AAPS Journal, AAPSPharmSciTech , or Pharmaceutical Research ), we can help make the peer review process faster and smoother by extending the use of previous peer reviewer comments! Portable Peer Review, an opt-into service available for any author of these journals, allows us to share, between the portfolio, previous peer review comments and reviewer names, subject to approval of all parties. This can help speed up the assessment process, should the editor choose to make a decision on the basis of the comments and revision. Interested?   Email us with the name of the journal to which you are going to submit. Note: Portable peer review is opt-in only, available at the authors’ preference, and the reviewer identities and comments will only be shared between offices, not to the author.

AAPS Pharmaceutical Research Meritorious Manuscript Award

AAPS Pharmaceutical Research Meritorious Manuscript Award Recognizing outstanding achievement in the pharmaceutical sciences as demonstrated by the author(s) in the quality and originality of a manuscript published in Pharmaceutical Research.  Watch the video here .

Awardee/Corresponding Author: Dennis Douroumis, Ph.D., University of Greenwich Co-Authors: Nicolaos Scoutaris, Ph.D. and Steven A. Ross, Ph.D.

Featured article

Repurposing of kinase inhibitors for treatment of COVID-19 There are three major needs that have yet to be met for effective management of COVID19 disease: 1) anti-viral therapies that limit viral transmission, cell entry, and replication, 2) therapies that attenuate the non-productive immune response and thus decrease end-organ damage, and 3) therapies that have an anti-fibrotic effect in patients with ARDS and thus decrease long-term sequelae of disease. Read the article above for the full review and proposal.

Announcing new Editor-in-Chief of AAPS Open: Dr. Andrea Allmendinger

AAPS Open is proud to announce new Editor-in-Chief Dr. Andrea Allmendinger. Dr. Allmendinger obtained her PhD in Pharmaceutical Technology from the University of Basel and joined the Pharmaceutical Development department of Roche/Genentech in Basel in 2013, where she is responsible for formulation and process development for clinical Phase I-III projects and commercial transfer activities for both large molecules and for synthetic drugs.

Journal information

• Biological Abstracts
• CAB Abstracts
• Chemical Abstracts Service (CAS)
• Current Contents/Life Sciences
• Google Scholar
• Japanese Science and Technology Agency (JST)
• OCLC WorldCat Discovery Service
• Pathway Studio
• Science Citation Index Expanded (SCIE)
• TD Net Discovery Service
• UGC-CARE List (India)

Rights and permissions

Springer policies

© Springer Science+Business Media, LLC, part of Springer Nature

• Find a journal
• Publish with us
• Track your research

ISSN (Online): 0975-8232, ISSN (Print): 2320-5148

International Journal Of Pharmaceutical Sciences And Research

An International Journal published monthly An Official Publication of Society of Pharmaceutical Sciences and Research

Overview of oral dispersible tablets.

The need to deliver pharmaceuticals to patients quickly and with minimal side effects has driven pharmaceutical companies to invest in the development of novel drug delivery systems. Solid dose forms, such as pills, are difficult for pediatric and geriatric patients to swallow. The best treatment for this issue is a mouth dissolving pill that dissolves or disintegrates quickly in the oral cavity. Additionally, they produce a pleasant tongue sensation. ODT has benefits like enhanced Bioavailability, rapid action, and patient compliance. As a result, mouth-dissolved tablets are a desirable substitute for liquid and traditional tablet dose forms. In recent past, several manufacturing technologies such as sublimation technique, spray drying technique etc. are employed to overcome the limitations of conventional tablet dosage forms. The mouth dissolving tablets must undergo a variety of evaluations after they are created in order to ensure their long-term stability and improved therapeutic effectiveness.

Article Information

Page No: 1340-1345

Size: 646 KB

Download: 11

Cited By: 0

Language: English

Licence: IJPSR

Authors: Preeti Sharma

Authors Address: Ram Gopal College of Pharmacy, Sultanpur, Gurugram, Haryana, India.

Email: [email protected]

Received: 30 September 2023

Revised: 02 April 2024

Accepted: 12 April 2024

DOI: 10.13040/IJPSR.0975-8232.15(5).1340-45

Published: 01 May 2024

• Editorial Board
• Current Issues
• Instructions to Authors
• Manuscript Submission
• Manuscript Tracking

All © 2024 are reserved by International Journal of Pharmaceutical Sciences and Research

This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License

Identifiers

Linking ISSN (ISSN-L): 0975-2366

URL http://www.ijpronline.com

Google https://www.google.com/search?q=ISSN+%220975-2366%22

Bing https://www.bing.com/search?q=ISSN+%220975-2366%22

Yahoo https://search.yahoo.com/search?p=ISSN%20%220975-2366%22

National Library of India http://nationallibraryopac.nvli.in/cgi-bin/koha/opac-search.pl?advsearch=1&idx=ns&q=0975-2366&weight_search=1&do=Search&sort_by=relevance

Resource information

Title proper: International journal of pharmaceutical research.

Country: India

Medium: Online

Record information

Last modification date: 06/02/2021

Type of record: Confirmed

ISSN Center responsible of the record: ISSN National Centre for India

downloads requested

Discover all the features of the complete ISSN records

Display mode x.

Labelled view

MARC21 view

UNIMARC view

• P-ISSN 0973-7200 E-ISSN 2454-8405

Journal of Pharmaceutical Research

Current issue.

Year: 2023, Volume: 22, Issue: 4

DON'T MISS OUT!

Subscribe now for latest articles and news.

Journal of International Pharmaceutical Research

About the journal.

International Journal of Pharmaceutical Research (ISSN: 1674-0440). People from various avenues of pharmacy profession, who have come together in a single platform to redefine the structure of pharmacy profession in the country, where it is seen only as an industry oriented profession. IJPR is peer reviewed online journal which is also available in print version. The motto behind the journal is to help students, researchers and scientist worldwide to benefit from the high quality peer reviewed articles and to their high performing works in the entire arena of pharmaceutical science.

Current Issue

Requirements and challenges of multicultural education in iran, clinical response and toxicities of tkls in advanced medullary thyroid cancer: systematic review and meta-analysis, a systematic and meta-analysis of survival and failure rates of orthodontic temporary anchorage devices in children, the efficacy of renin angiotensin system inhibitors (rasi) in patients with coronary artery disease without heart failure: systematic review and meta-analysis, different scaling approaches used in pediatric pharmacotherapy as well as their proper implementation in drug development and clinical use systematic review and meta-analysis, islamic medicine during the caliphs, gender differences in happiness among the nurses, clinical applications f artificial intelligence in dental and maxillofacial radiology among children: a systematic review and meta-analysis, investigating the dimensions of patient safety indices, epidemiologic study of acute and chronic brucellosis in patients referred to yasuj shahid mofateh clinic from september 2018 to march 201997, evaluation of image quality of the heart spect by modifying the imaging protocol: a phantom study, effect of oral progesterone (dydrogestron) on incidence of glucose intolerance in pregnant females with threatened abortion referred to clinics of shiraz medical university hospitals, impact of individual and social consequences of prayer on the health of the body and soul, with emphasis on the teachings of razavi, a study on the pattern of inotropes use in an intensive care unit, due of aminoglycosides in patients admitted to icu of the shiraz namazi hospital, clinical and functional parallels of severe uncontrolled asthmain children, role of transforming growth factor beta 1 in non alcoholic fatty liver diabetes patients, hepatic and renal status of patients with sickle cell-β thalassemia in thi-qar province/iraq, prevalence of tubal blockage via hystero salpingography in iraqi infertile women, effect of isosorbide dinitrate in lipid profile and oxidant-antioxidant markers of hypercholesterolemia female rats, molecular characterization of ctx-m-15 β-lactamase from clinical isolate of klebsiella pneumoniae sj16, correlation between serum nitric oxide levels and lipid profile in several types of arterial occlusion in atherosclerosis cardiovascular patients, synthesis and identification of new organoselenium compounds derived from 4-[chloromethyl]-2-hydroxybenzaldehyde, synthesis and characterization of some new 3, 4dihydropyrimidinone derivatives, rules and regulations of the hospital, development and evaluation of natural cosmeceutical ingredients as makeup remover to prevent hyperpigmentation.

• Editorial Board
• Instruction to Authors
• Current Issue
• Article In Press
• Table Of Contents

• Search Menu
• Advance Articles
• Themed Collections
• Supplements
• Author Guidelines
• Submission Site
• Open Access Options
• Self-Archiving Policy
• Call for Papers
• About International Journal of Pharmacy Practice
• About the Royal Pharmaceutical Society
• Editorial Board
• Advertising & Corporate Services
• Journals on Oxford Academic
• Books on Oxford Academic

Article Contents

• < Previous

Core components of pharmacist-led medication reviews and their relationship to outcomes: a systematic review

• Article contents
• Figures & tables
• Supplementary Data

M E Craske, W Hardeman, N Steel, M J Twigg, Core components of pharmacist-led medication reviews and their relationship to outcomes: a systematic review, International Journal of Pharmacy Practice , Volume 32, Issue Supplement_1, April 2024, Pages i52–i53, https://doi.org/10.1093/ijpp/riae013.066

• Permissions Icon Permissions

Medication reviews are a recognised intervention undertaken by healthcare professionals to support patients prescribed multiple medicines or with complex medication regimens. Pharmacist-led medication reviews are now an established intervention in policy and practice. There are different types of medication review, each implemented differently. Huiskes et al . demonstrated that medication reviews undertaken by any professional in any setting had minimal effects on clinical outcomes and that evidence is lacking about their effect on economic outcomes. [1] The implementation of medication reviews in practice was recognised as a factor which may impact outcomes, but this has not been explored further.

To develop an initial programme theory that links the core components of pharmacist-led medication reviews to outcomes in different contexts.

A systematic review was conducted to identify randomised controlled trials of medication reviews in adults (18+). The review updated that by Huiskes et al . and used the same search strategy in the MEDLINE, EMBASE and Web of Science databases. [1] The search terms used were related to ‘medication review’, ‘pharmacist’ and ‘randomised controlled trial’. Medication review was defined as “ a consultation between a pharmacist and a patient to review the patient’s total medicines use with a view to improve patient health outcomes and minimise medicines related problems ”. Studies reporting any outcomes were included. Papers not published in English or not available as full texts were excluded. The Cochrane Risk of Bias 2.0 tool was used to assess the studies. Data were extracted using a previously piloted bespoke data collection form. Descriptions of the medication reviews’ core components, implementation and outcomes were narratively synthesised to draw out common themes. The GRADE framework informed the overall assessment of the quality of the evidence from the studies. [2]

Records screened n= 10947, total reports of studies included n= 68. Of the 50 individual studies that were identified, 66% were assessed as having a high risk of bias. Narrative synthesis of the data extracted relating to the description and implementation of the medication reviews, and where and how this may have affected outcomes, is presented in our programme theory as core components. Collaborative working may help reduce medicines-related problems and number of medicines prescribed. Patient involvement in goal setting and action planning may improve patients’ ability to take medicines as prescribed and help them achieve their treatment goals. Additional support and follow-up may lead to improved blood pressure, diabetes control, quality of life and a reduction of medicines-related problems.

This is an extensive systematic review that has explored pharmacist-led medication reviews in all settings and resulted in the production of a draft programme theory. It is best practice for stakeholders to be involved in the development of a programme theory. Providers of medication reviews can evaluate their processes and consider if and how these core components are implemented in their service provision. This initial programme theory will be refined and discussed in future research.

1. Huiskes VJB, Burger DM, Van Den Ende CHM et al . Effectiveness of medication review: A systematic review and meta-analysis of randomized controlled trials. BMC Fam Pract. 2017;18.

2. Guyatt GH, Oxman AD, Kunz R et al . Going from evidence to recommendations. BMJ. 2008;336:1049–51.

Email alerts

Citing articles via.

• Recommend to Your Librarian
• Advertising and Corporate Service
• Journals Career Network

Affiliations

• Online ISSN 2042-7174
• Print ISSN 0961-7671
• Copyright © 2024 Royal Pharmaceutical Society
• About Oxford Academic
• Publish journals with us
• University press partners
• What we publish
• New features  
• Open access
• Institutional account management
• Rights and permissions
• Get help with access
• Accessibility
• Advertising
• Media enquiries
• Oxford University Press
• Oxford Languages
• University of Oxford

Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide

• Copyright © 2024 Oxford University Press
• Cookie settings
• Cookie policy
• Privacy policy
• Legal notice

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This PDF is available to Subscribers Only

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.